EYEMOVE
Partnership
Leave your contacts, we will call you back

EYEMOVE

Online screening for Alzheimer's and Parkinson's diseases based on eye movements
Dementia is one of the primary reasons for disability and dependence among elderly people around the world.
47.5 million people worldwide are affected by Dementia.
Of those, 28 million are affected with Alzheimer's disease and 6 million are affected with Parkinson's disease.
Why should I know about the disease if it can't be cured?
procrastination
In the early stages of the disease, symptoms may not appear for 5-10 years
SUPPORT
These diseases not only affect the patient, but also family and friends as they watch a loved one suffer
Financial
With modern diagnostics, it's now cheaper and easier than ever to fight these diseases in their early stages
Run a diagnostic
The online assessment aids in the detection of Alzheimer's and Parkinson's diseases.
During the assessment, your eyes are given simple tests to evaluate their reaction time, movement time, and movement path (trajectory). The test results are compared against our database and a probability of having Dementia is calculated.
Advantages
Сonveniently
Do not go out and visit a polyclinic
Quickly
It takes 5 minutes for diagnostic
Technical equipment
Needed a high resolution camera - from 120 fps and higher for diagnostic
Painless
No physical (invasive) intervention required
Online
Diagnostic results are sent to e-mail within 1 day
Read more about preparation
and frequently asked questions
Scientific publications
Description of clinical studies and scientific articles
of Russian and foreign scientists of the eyes movement in the early stages of the dementia development (Alzheimer's, Parkinson's), as well as their relatives and healthy people.
Medical partners
Baziyan Boris Khorenovich,
Neurophysiologist,
Doctor of Biological Sciences,
Head. Laboratory of Neurocybernetics
Maria Gantman,
Scientific doctor of the Department
of Alzheimer's Disease
Alexey Melekhin
Clinical psychologist of the highest qualification category, gerontopsychotherapist of the Russian gerontological scientific and clinical center (Moscow)
"The EyeMove is undoubtedly the area of fundamental medicine, due to the fact that the population is aging rapidly at the moment, which is accompanied by an increase in various somatic, mental and social risks, leading to a premature or unfavorable course of aging (senile asthenia). Especially acute in gerontology and geriatrics there is the issue of early recognition of the risks of neurodegenerative (Alzheimer's, Parkinson's) and mental disorders in elderly and senile people (Depression, anxiety disorders, psychosis). However, at the moment both in the domestic and foreign geriatrics, neurology and gerontopsychiatry there are a few tools (diagnostic techniques) and diagnostic algorithms that can help in solving this problem.
I want to wish the Eyemove development team to move further in achieving the goals. We, from the Institute of Psychology of the Russian Academy of Sciences and the Russian gerontological scientific and clinical centre, are ready to scientifically and methodically help this project."
Maria Gantman
Scientific doctor of the Department of Alzheimer's Disease
слова слова слова
Mass media and
the company development
Read mass media reports about us or watch the video of our speeches about the development and achievements of the company
Check yourself
Sign up for diagnostic right now!
Use a webcam or a mobile phone camera!
Sign up for a screening
Made on
Tilda